Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Intensive care medicine 25 (1999), S. 1282-1286 
    ISSN: 1432-1238
    Keywords: Key words Cerebral perfusion pressure ; Intracranial pressure ; Mean arterial pressure ; Endothelium ; Pressure autoregulation ; Cerebral blood flow
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective: To investigate the role of the endothelin system in pressure autoregulation of cerebral blood flow (CBF) in rats.¶Design: We tested pressure autoregulation by increasing cerebral perfusion pressure (CPP; mean arterial pressure–intracranial pressure) with norepinephrine (0.08 μg · kg−1· min−1 for 30 min) twice in ten anesthetized normocapnic rats. The first test was performed without (control test) and the second test after administration of the combined endothelin ETA/B receptor antagonist, bosentan, i. v. (30 mg/kg; drug test). CBF was measured by the hydrogen clearance technique.¶Results: During the control test, norepinephrine infusion increased CPP by 21 ± 2 (23 ± 2 %) mmHg (mean ± SEM; p 〈 0.001) and CBF by 3.6 ± 3.1 (6 ± 8 %) ml/100 g/min (p = 0.5, Fig. 1); during the drug test, norepinephrine infusion increased CPP by 18 ± 1 (20 ± 2 %) mmHg (p 〈 0.001) and CBF by 15.8 ± 4.1 (46 ± 13 %) ml/100 g/min (p = 0.004). Mean arterial pressure was not affected by bosentan infusion (p = 0.2). PaC02 levels were stable during the tests (40.2 ± 1.4 mmHg).¶Conclusions: The endothelin system is involved in cerebral pressure autoregulation in a rodent model in vivo. The role of this system under pathophysiologic conditions such as subarachnoid hemorrhage, where basal vascular tone and its regulation may be altered, remains to be defined.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1365-2044
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Assessment of cerebral oxygenation using near-infrared spectroscopy in intensive care is increasing. We compared the ability of the Invos 3100 and the Critikon 2020 monitors to produce stable and consistent readings of regional cerebral oxygen saturation in resting volunteers. Failure to obtain any stable reading with the Critikon occurred in eight out of 18 subjects (44.4%) and with the Invos in three out of 15 subjects (20%). The Critikon showed a significantly higher failure rate in male subjects (p = 0.0011). Differences in recorded values of cerebral oxygen saturation (Critikon − Invos) ranged from −4.7% to 12.6% and were significantly related to the average saturation level (p 〈 0.0001). The within-monitor variability was significantly higher for the Invos (p = 0.0124). Neither monitor is able to give stable and consistent readings over time, particularly in male subjects. The unacceptably high failure rate of the recently introduced Critikon 2020 will limit or prevent its clinical use.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Science Ltd
    Anaesthesia 57 (2002), S. 0 
    ISSN: 1365-2044
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Summary Respiratory monitoring is an important aspect of critical care, especially in neurosurgery and neuro-intensive care. Fixed capnographs are too cumbersome to allow monitoring during patient transport. Recently several portable expired fraction carbon dioxide devices have been developed, but no evaluation of their clinical peformance has been reported. We compared the Criticare POET LT Handheld expired fraction carbon dioxide monitor, in three different settings, to fixed capnographs and arterial blood gas analysis. A methodology for systematic appraisal of end-tidal capnographs is proposed.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1432-1238
    Keywords: Key words Cerebral blood flow ; CPP management ; Intracranial pressure ; Pressure autoregulation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective: To ascertain if norepinephrine can be used as part of the cerebral perfusion pressure (CPP) management to increase arterial blood pressure (MAP) without causing cerebral hyperemia after severe head injury (HI).¶Design: Prospective, interventional study.¶Setting: Intensive care unit in a university hospital.¶Patients: Twelve severely HI patients; median Glasgow Coma Scale was 6 (range 3–8).¶Interventions: CPP management ( = 70 mmHg). Pressure autoregulation (assessed by norepinephrine infusion) was defined intact if %CPP/%CVR ≤ 2.¶Results: Cerebral blood flow (CBF: Xe133 inhalation technique), jugular bulb oxygen saturation (SjO2) and transcranial Doppler (TCD) were recorded during the test. Norepinephrine increased CPP by 33 % ( ± 4). Autoregulation was found to be intact in ten patients and defective in two. In the ten patients with preserved autoregulation, CBF decreased from 31 ± 3 to 28 ± 3 ml/100 g/min; in the two patients with impaired autoregulation CBF increased respectively from 16 to 35 and from 21 to 70 ml/100 g/min. SjO2 did not change significantly from baseline. TCD remained within the normal range.¶Conclusions: During CPP management norepinephrine can be used to increase MAP without potentiating hyperemia if pressure autoregulation is preserved. The assessment of pressure autoregulation should be considered as a guide for arterial pressure-oriented therapy after HI.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...